HOONMO KOO to Treatment Outcome
This is a "connection" page, showing publications HOONMO KOO has written about Treatment Outcome.
Connection Strength
0.095
-
Future novel therapeutic agents for Clostridium difficile infection. Expert Opin Investig Drugs. 2010 Jul; 19(7):825-36.
Score: 0.027
-
Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol. 2010 Jan; 26(1):17-25.
Score: 0.026
-
Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis. Clin Infect Dis. 2009 Mar 01; 48(5):598-605.
Score: 0.025
-
Incidence and Clinical Outcomes of Clostridium difficile Infection after Treatment with Tuberculosis Medication. Gut Liver. 2016 Mar; 10(2):250-4.
Score: 0.010
-
Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance. Expert Rev Anti Infect Ther. 2010 May; 8(5):555-64.
Score: 0.007